Latest Breaking News On - Ebook number - Page 3 : comparemela.com

Published: Jun 09, 2021 NEW YORK, June 09, 2021 (GLOBE NEWSWIRE) TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of upcoming data presentations at the 16 th International Congress on Malignant Lymphoma (ICML), being held virtually June 18 – 22, 2021. Details of the data presentations are included below. Poster Presentation Title : TG-1701, A Selective Bruton Tyrosine Kinase (BTK) Inhibitor, as Monotherapy and in Combination with Ublituximab and Umbralisib (U2) in Patients with B-cell Malignancies Abstract Book Number: 236 Presentation Available on Demand: Friday, June 18, 2021 at 9:00 CEST Lead Author: Chan Y. Cheah MBBS, DMSc, Linear Clinical Research, and Department of Haematology, Sir Charles Gairdner Hospital, Nedlands Western Australia, Medical School, University of Western Australia, Crawley, Western Australia

Western australiaChany cheahInternational congress on malignant lymphomaDepartment of haematologyJosep carreras leukaemia research instituteUniversity of western australiaExchange commissionLinear clinical researchGlobe newswire tg therapeutics incTg therapeutics incLymphoma translational groupInternational congressMalignant lymphomaPresentation titleSelective bruton tyrosine kinaseEbook number